author-photo

Lacey McQuinn

University of Texas MD Anderson Cancer Center

22

Papers

133

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

Effects of glutamine for prevention of radiation-induced esophagitis: a double-blind placebo-controlled trial.

2021 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (0)
Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study (Investigational New Drugs, (2021), 39, 5, (1357-1365), 10.1007/s10637-021-01119-0)

2021 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (0)
Selinexor in combination with weekly paclitaxel in patients with advanced or metastatic solid tumors: Results of an open label, single-center, multiarm phase 1b study.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single‑center, multi‑arm phase Ib study (Investigational New Drugs, (2021), 10.1007/s10637-021-01188-1)

2021 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (0)
Lost in Translation: Interprofessional Collaborative Practice Across the Continuum of Care

2020
Show All
- Source
- Cite
- Save
Citations (0)
Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory.

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Prevalence of Complementary Medicine Use in Patients With Cancer: A Turkish Comprehensive Cancer Center Experience

2018 Journal of Global Oncology
Show All
- Source
- Cite
- Save
Citations (9)
Phase II study for the evaluation of efficacy of pembrolizumab (MK-3475) in patients with cancer of unknown primary.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Incidence of mucositis in patients treated with mTOR inhibitor-based regimens and correlation to treatment response.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Phase I dose escalation study of temsirolimus in combination with metformin in patients with advanced/refractory cancers.

2016 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (27)